NCT04204447 is a NA clinical trial of Hepatitis C Educational Brochure in Hepatitis C, sponsored by State University of New York at Buffalo.

Who is sponsoring NCT04204447?

NCT04204447 is sponsored by State University of New York at Buffalo.

What drugs are being tested in NCT04204447?

Interventions in NCT04204447: Hepatitis C Educational Brochure, Hepatitis C Educational Video.

What condition does NCT04204447 study?

NCT04204447 studies Hepatitis C.

Is NCT04204447 still recruiting?

NCT04204447 is currently completed. Last updated 19 September 2024.

Are results published for NCT04204447?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-09-19 · How we verify

NCT04204447

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hepatitis C-Video vs. Brochure Education Delivery

Completed NA Results posted Last updated 19 September 2024

What this trial tests

NA trial testing Hepatitis C Educational Brochure in Hepatitis C in 176 participants. Completed in 31 October 2020.

Timeline

27 November 2019

Primary endpoint
31 October 2020

31 October 2020

Quick facts

Lead sponsor	State University of New York at Buffalo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	176
Start date	27 November 2019
Primary completion	31 October 2020
Estimated completion	31 October 2020
Sites	2 locations across United States

Drugs / interventions tested

Hepatitis C Educational Brochure
Hepatitis C Educational Video

Conditions studied

Hepatitis C — all drugs for Hepatitis C →

Sponsor

State University of New York at Buffalo

Who can join

18 and older, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Improvement in Scores on HCV Knowledge Questionnaire Primary · Pre-intervention, Immediate post-intervention, and 1 mo. follow up

The main outcome measure was a change in the mean score on a 25-item HCV knowledge assessment without subscales. The instrument values ranged from 0 to 25 with one point per correct answer to questions directly arising from the information contained in the video. One point was assigned to each correct answer, and an increase in the score indicated more correct responses.

Pre-intervention

Group	Value	95% CI
Brochure Intervention	18.45	± .3
Video Intervention	19	± 0.25

Immiediate post-intervention

Group	Value	95% CI
Brochure Intervention	20.3	± .35
Video Intervention	21.75	± 0.3

One month post-intervention

Group	Value	95% CI
Brochure Intervention	20.2	± .3
Video Intervention	21.7	± 0.2

Sponsor's own description

The purpose of this study is to determine the most effective way to give patients information regarding hepatitis C virus infection. The investigators plan to compare the information retained by some patients who are given a brochure alone versus patients who watch an interactive video about hepatitis C.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Innovations in education: A prospective study of storytelling narratives to enhance hepatitis C virus knowledge among substance users.
Talal AH, Ding YX, Markatou M. · · 2022 · cited 4× · PMID 35721284 · DOI 10.4254/wjh.v14.i5.972

Verify or expand the search:

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Other State University of New York at Buffalo trials

Trials by the same sponsor.

NCT07072767 — Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation · NA · not yet recruiting
NCT07140848 — CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes · NA · not yet recruiting
NCT07433959 — Neuromodulation to Improve Grasping Function After SCI · NA · not yet recruiting
NCT07403539 — Speech Learning and Speech Production in Parkinson's Disease · NA · recruiting
NCT05367362 — Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute · Phase 2 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04204447 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State University of New York at Buffalo
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04204447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing